mouse primary antibodies Search Results


93
Qiagen mouse primary antibody α his
Mouse Primary Antibody α His, supplied by Qiagen, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse primary antibody α his/product/Qiagen
Average 93 stars, based on 1 article reviews
mouse primary antibody α his - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

93
Rockland Immunochemicals affinity
Affinity, supplied by Rockland Immunochemicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/affinity/product/Rockland Immunochemicals
Average 93 stars, based on 1 article reviews
affinity - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

93
Quidel primary mouse antibody α c4c
Primary Mouse Antibody α C4c, supplied by Quidel, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/primary mouse antibody α c4c/product/Quidel
Average 93 stars, based on 1 article reviews
primary mouse antibody α c4c - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

90
Abnova 4-hydroxy-2-nonenal (4-hne) mouse primary antibody
4 Hydroxy 2 Nonenal (4 Hne) Mouse Primary Antibody, supplied by Abnova, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/4-hydroxy-2-nonenal (4-hne) mouse primary antibody/product/Abnova
Average 90 stars, based on 1 article reviews
4-hydroxy-2-nonenal (4-hne) mouse primary antibody - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Fisher Scientific mouse primary antibody against glyceraldehyde-3phosphate dehydrogenase (gapdh
Mouse Primary Antibody Against Glyceraldehyde 3phosphate Dehydrogenase (Gapdh, supplied by Fisher Scientific, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse primary antibody against glyceraldehyde-3phosphate dehydrogenase (gapdh/product/Fisher Scientific
Average 90 stars, based on 1 article reviews
mouse primary antibody against glyceraldehyde-3phosphate dehydrogenase (gapdh - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Abmart Inc mouse anti-duox primary antibody
Mouse Anti Duox Primary Antibody, supplied by Abmart Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse anti-duox primary antibody/product/Abmart Inc
Average 90 stars, based on 1 article reviews
mouse anti-duox primary antibody - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Argene Inc primary mouse antibody e13
Primary Mouse Antibody E13, supplied by Argene Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/primary mouse antibody e13/product/Argene Inc
Average 90 stars, based on 1 article reviews
primary mouse antibody e13 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
ImmunoStar inc mouse anti-th primary antibodies
Mouse Anti Th Primary Antibodies, supplied by ImmunoStar inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse anti-th primary antibodies/product/ImmunoStar inc
Average 90 stars, based on 1 article reviews
mouse anti-th primary antibodies - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
GeneTex primary mouse monoclonal antibody specific to the viral spike glycoprotein 1a9 clone
Replication synergy in co-infection of SARS-CoV-2 variants and high antiviral potency of TG against all variants . Confluent cells were primed with 0.5 µM TG or DMSO control for 30 min, washed twice with PBS, and infected with A variant, B variant, and D variant at 0.1 MOI in single virus infections (A, B and D) and in co-infections (AB, AD, and BD) for 1.5 h, washed twice with PBS and incubated in infection media. Notably, co-infected cells received the same amount of each virus as used in single virus infection. At 24 (panel a) and 72 hpi (panel a and b), total viral RNA from media was subjected to one-step reverse transcription qPCR, using primer set (1, 2) specific to all 3 variants, to quantify viral spike <t>glycoprotein</t> RNA by relative Ct method. Synergy in progeny production was evident in AB and AD co-infections where total virus RNA detected was greater than the sum of corresponding single-virus infection RNA evident at 24 and 72 hpi (panel a). Indicated significance relative to corresponding A/DMSO control based on 2-way ANOVA with Tukey’s multiple comparisons. Replication of all single virus- and co-infections was effectively blocked for at least 3 days by single pre-infection priming of TG. In AD co-infection, the most prolific infection group, combined viral RNA from TG-primed cells fell by 99.6% relative to corresponding DMSO control (panel b). Indicated significance relative to corresponding DMSO control based on 2-way ANOVA with Sidak’s multiple comparisons. Data shown are representative of three independent experiments and performed in quadruplicates
Primary Mouse Monoclonal Antibody Specific To The Viral Spike Glycoprotein 1a9 Clone, supplied by GeneTex, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/primary mouse monoclonal antibody specific to the viral spike glycoprotein 1a9 clone/product/GeneTex
Average 90 stars, based on 1 article reviews
primary mouse monoclonal antibody specific to the viral spike glycoprotein 1a9 clone - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Cedarlane mouse cd4 monoclonal antibody
Replication synergy in co-infection of SARS-CoV-2 variants and high antiviral potency of TG against all variants . Confluent cells were primed with 0.5 µM TG or DMSO control for 30 min, washed twice with PBS, and infected with A variant, B variant, and D variant at 0.1 MOI in single virus infections (A, B and D) and in co-infections (AB, AD, and BD) for 1.5 h, washed twice with PBS and incubated in infection media. Notably, co-infected cells received the same amount of each virus as used in single virus infection. At 24 (panel a) and 72 hpi (panel a and b), total viral RNA from media was subjected to one-step reverse transcription qPCR, using primer set (1, 2) specific to all 3 variants, to quantify viral spike <t>glycoprotein</t> RNA by relative Ct method. Synergy in progeny production was evident in AB and AD co-infections where total virus RNA detected was greater than the sum of corresponding single-virus infection RNA evident at 24 and 72 hpi (panel a). Indicated significance relative to corresponding A/DMSO control based on 2-way ANOVA with Tukey’s multiple comparisons. Replication of all single virus- and co-infections was effectively blocked for at least 3 days by single pre-infection priming of TG. In AD co-infection, the most prolific infection group, combined viral RNA from TG-primed cells fell by 99.6% relative to corresponding DMSO control (panel b). Indicated significance relative to corresponding DMSO control based on 2-way ANOVA with Sidak’s multiple comparisons. Data shown are representative of three independent experiments and performed in quadruplicates
Mouse Cd4 Monoclonal Antibody, supplied by Cedarlane, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse cd4 monoclonal antibody/product/Cedarlane
Average 90 stars, based on 1 article reviews
mouse cd4 monoclonal antibody - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Biogenex mouse anti-mbp primary antibody
Replication synergy in co-infection of SARS-CoV-2 variants and high antiviral potency of TG against all variants . Confluent cells were primed with 0.5 µM TG or DMSO control for 30 min, washed twice with PBS, and infected with A variant, B variant, and D variant at 0.1 MOI in single virus infections (A, B and D) and in co-infections (AB, AD, and BD) for 1.5 h, washed twice with PBS and incubated in infection media. Notably, co-infected cells received the same amount of each virus as used in single virus infection. At 24 (panel a) and 72 hpi (panel a and b), total viral RNA from media was subjected to one-step reverse transcription qPCR, using primer set (1, 2) specific to all 3 variants, to quantify viral spike <t>glycoprotein</t> RNA by relative Ct method. Synergy in progeny production was evident in AB and AD co-infections where total virus RNA detected was greater than the sum of corresponding single-virus infection RNA evident at 24 and 72 hpi (panel a). Indicated significance relative to corresponding A/DMSO control based on 2-way ANOVA with Tukey’s multiple comparisons. Replication of all single virus- and co-infections was effectively blocked for at least 3 days by single pre-infection priming of TG. In AD co-infection, the most prolific infection group, combined viral RNA from TG-primed cells fell by 99.6% relative to corresponding DMSO control (panel b). Indicated significance relative to corresponding DMSO control based on 2-way ANOVA with Sidak’s multiple comparisons. Data shown are representative of three independent experiments and performed in quadruplicates
Mouse Anti Mbp Primary Antibody, supplied by Biogenex, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse anti-mbp primary antibody/product/Biogenex
Average 90 stars, based on 1 article reviews
mouse anti-mbp primary antibody - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
GenScript corporation rabbit anti-mouse fmo3 primary antibody
Livers were collected from mice (n=6) sacrificed at respective time-points (2,4,8,12,24 & 48h for ANIT; 24 & 48h for CCl4; 6 & 24h for AlOH; and 10 d for BDL). RNA was isolated and cDNA was made using a commercial MMLV-RT kit. The cDNA samples were analyzed by quantitative RT-PCR using <t>Fmo3</t> mouse-specific primers. Gene expression was normalized to the housekeeping gene β-actin. Fmo3 mRNA expression is presented as mean Fold Change ± SE. One-way ANOVA, t-test or two-way ANOVA was performed, appropriately, followed by the Dunnett's posttest for One-way ANOVA and the Bonferroni posttest for two-way ANOVA. Asterisks (*) represent a statistical difference (p < 0.05) between vehicle-treated and hepatotoxicant-treated or BDL group.
Rabbit Anti Mouse Fmo3 Primary Antibody, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti-mouse fmo3 primary antibody/product/GenScript corporation
Average 90 stars, based on 1 article reviews
rabbit anti-mouse fmo3 primary antibody - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


Replication synergy in co-infection of SARS-CoV-2 variants and high antiviral potency of TG against all variants . Confluent cells were primed with 0.5 µM TG or DMSO control for 30 min, washed twice with PBS, and infected with A variant, B variant, and D variant at 0.1 MOI in single virus infections (A, B and D) and in co-infections (AB, AD, and BD) for 1.5 h, washed twice with PBS and incubated in infection media. Notably, co-infected cells received the same amount of each virus as used in single virus infection. At 24 (panel a) and 72 hpi (panel a and b), total viral RNA from media was subjected to one-step reverse transcription qPCR, using primer set (1, 2) specific to all 3 variants, to quantify viral spike glycoprotein RNA by relative Ct method. Synergy in progeny production was evident in AB and AD co-infections where total virus RNA detected was greater than the sum of corresponding single-virus infection RNA evident at 24 and 72 hpi (panel a). Indicated significance relative to corresponding A/DMSO control based on 2-way ANOVA with Tukey’s multiple comparisons. Replication of all single virus- and co-infections was effectively blocked for at least 3 days by single pre-infection priming of TG. In AD co-infection, the most prolific infection group, combined viral RNA from TG-primed cells fell by 99.6% relative to corresponding DMSO control (panel b). Indicated significance relative to corresponding DMSO control based on 2-way ANOVA with Sidak’s multiple comparisons. Data shown are representative of three independent experiments and performed in quadruplicates

Journal: Virulence

Article Title: Emergent SARS-CoV-2 variants: comparative replication dynamics and high sensitivity to thapsigargin

doi: 10.1080/21505594.2021.2006960

Figure Lengend Snippet: Replication synergy in co-infection of SARS-CoV-2 variants and high antiviral potency of TG against all variants . Confluent cells were primed with 0.5 µM TG or DMSO control for 30 min, washed twice with PBS, and infected with A variant, B variant, and D variant at 0.1 MOI in single virus infections (A, B and D) and in co-infections (AB, AD, and BD) for 1.5 h, washed twice with PBS and incubated in infection media. Notably, co-infected cells received the same amount of each virus as used in single virus infection. At 24 (panel a) and 72 hpi (panel a and b), total viral RNA from media was subjected to one-step reverse transcription qPCR, using primer set (1, 2) specific to all 3 variants, to quantify viral spike glycoprotein RNA by relative Ct method. Synergy in progeny production was evident in AB and AD co-infections where total virus RNA detected was greater than the sum of corresponding single-virus infection RNA evident at 24 and 72 hpi (panel a). Indicated significance relative to corresponding A/DMSO control based on 2-way ANOVA with Tukey’s multiple comparisons. Replication of all single virus- and co-infections was effectively blocked for at least 3 days by single pre-infection priming of TG. In AD co-infection, the most prolific infection group, combined viral RNA from TG-primed cells fell by 99.6% relative to corresponding DMSO control (panel b). Indicated significance relative to corresponding DMSO control based on 2-way ANOVA with Sidak’s multiple comparisons. Data shown are representative of three independent experiments and performed in quadruplicates

Article Snippet: Briefly, Vero E6 cells infected with a fixed volume of supernatant for 18 h were fixed with 4% paraformaldehyde in PBS for 15 min, permeabilized with 0.1% Triton X-100 in PBS for 10 min, washed three times with PBS, followed by peroxidase treatment for 10 min and incubation with a 1:1000 dilution of primary mouse monoclonal antibody, specific to the viral spike glycoprotein (1A9 clone, GeneTex GTX632604), at room temperature for 1 h. The cells were then washed with Tris-buffered saline (TBS), incubated with horse radish peroxidase-labeled polymer for 1 h. After further washing with TBS, the cells were incubated with DAB substrate-chromogen solution for a few min (Envision+ system-HRP kit, Dako).

Techniques: Infection, Control, Variant Assay, Virus, Incubation, Reverse Transcription

Replication comparisons of each variant in single virus- and co-infections . Confluent Calu-3 cells were primed with 0.5 µM TG or DMSO control for 30 min, washed twice with PBS, and infected with A variant, B variant, and D variant at 0.1 MOI in single variant infections (A, B and D) and in co-infections (AB, AD, and BD) for 1.5 h, washed twice with PBS and incubated in infection media. Co-infected cells received the same amount of each virus as in single variant infection. At 24, 48 and 72 hpi, viral RNA from media was subjected to one-step reverse transcription qPCR with variant-specific primers that can discriminate between variants in co-infected samples to detect relative spike glycoprotein gene expression. All single variant- and co-infections were blocked for at least 3 days by single pre-infection priming of TG (panels a to c). Production of A variant vRNA in AB and AD co-infections at 72 hpi was clearly enhanced (relative to single-virus A variant infection) (panel a). Production of B variant vRNA in BA and BD co-infections at 72 hpi was also enhanced (panel b). However, production of D variant vRNA in DA and DB co-infections at 72 hpi was attenuated relative to single-variant D variant infection; reduction of the D variant vRNA in DA was more than 2 times that in DB co-infection (panel c). Unless otherwise indicated significance relative to corresponding DMSO control based on 2-way ANOVA with Tukey’s multiple comparisons; % reduction is relative to corresponding DMSO group. Data shown are representative of three independent experiments and performed in quadruplicates

Journal: Virulence

Article Title: Emergent SARS-CoV-2 variants: comparative replication dynamics and high sensitivity to thapsigargin

doi: 10.1080/21505594.2021.2006960

Figure Lengend Snippet: Replication comparisons of each variant in single virus- and co-infections . Confluent Calu-3 cells were primed with 0.5 µM TG or DMSO control for 30 min, washed twice with PBS, and infected with A variant, B variant, and D variant at 0.1 MOI in single variant infections (A, B and D) and in co-infections (AB, AD, and BD) for 1.5 h, washed twice with PBS and incubated in infection media. Co-infected cells received the same amount of each virus as in single variant infection. At 24, 48 and 72 hpi, viral RNA from media was subjected to one-step reverse transcription qPCR with variant-specific primers that can discriminate between variants in co-infected samples to detect relative spike glycoprotein gene expression. All single variant- and co-infections were blocked for at least 3 days by single pre-infection priming of TG (panels a to c). Production of A variant vRNA in AB and AD co-infections at 72 hpi was clearly enhanced (relative to single-virus A variant infection) (panel a). Production of B variant vRNA in BA and BD co-infections at 72 hpi was also enhanced (panel b). However, production of D variant vRNA in DA and DB co-infections at 72 hpi was attenuated relative to single-variant D variant infection; reduction of the D variant vRNA in DA was more than 2 times that in DB co-infection (panel c). Unless otherwise indicated significance relative to corresponding DMSO control based on 2-way ANOVA with Tukey’s multiple comparisons; % reduction is relative to corresponding DMSO group. Data shown are representative of three independent experiments and performed in quadruplicates

Article Snippet: Briefly, Vero E6 cells infected with a fixed volume of supernatant for 18 h were fixed with 4% paraformaldehyde in PBS for 15 min, permeabilized with 0.1% Triton X-100 in PBS for 10 min, washed three times with PBS, followed by peroxidase treatment for 10 min and incubation with a 1:1000 dilution of primary mouse monoclonal antibody, specific to the viral spike glycoprotein (1A9 clone, GeneTex GTX632604), at room temperature for 1 h. The cells were then washed with Tris-buffered saline (TBS), incubated with horse radish peroxidase-labeled polymer for 1 h. After further washing with TBS, the cells were incubated with DAB substrate-chromogen solution for a few min (Envision+ system-HRP kit, Dako).

Techniques: Variant Assay, Virus, Control, Infection, Incubation, Reverse Transcription, Gene Expression

Comparative vRNA production of emergent SARS-CoV-2 variants . Confluent Calu-3 cells were primed with 0.5 µM TG or DMSO control for 30 min, washed twice with PBS, and separately infected with A variant, B variant, and D variant at 0.1 MOI in for 1.5 h, washed twice with PBS and incubated in infection media. At 24, 48 and 72 hpi, viral RNA from media was subjected to one-step reverse transcription qPCR with variant-specific primer sets to detect relative spike glycoprotein RNA of each variant. Increase of virus output of each variant was determined between the periods of 24 to 48 hpi, and 24 to 72 hpi. Relative rates of progeny virus production of variants are such that D > A > B (panel a). Relative increase in virus output under TG inhibition (panel b) followed the same pattern as DMSO controls but was drastically reduced. Indicated significance of D is relative to B and A variants of each corresponding interval period based on 2-way ANOVA with Tukey’s multiple comparisons. Data shown are representative of three independent experiments and performed in quadruplicates

Journal: Virulence

Article Title: Emergent SARS-CoV-2 variants: comparative replication dynamics and high sensitivity to thapsigargin

doi: 10.1080/21505594.2021.2006960

Figure Lengend Snippet: Comparative vRNA production of emergent SARS-CoV-2 variants . Confluent Calu-3 cells were primed with 0.5 µM TG or DMSO control for 30 min, washed twice with PBS, and separately infected with A variant, B variant, and D variant at 0.1 MOI in for 1.5 h, washed twice with PBS and incubated in infection media. At 24, 48 and 72 hpi, viral RNA from media was subjected to one-step reverse transcription qPCR with variant-specific primer sets to detect relative spike glycoprotein RNA of each variant. Increase of virus output of each variant was determined between the periods of 24 to 48 hpi, and 24 to 72 hpi. Relative rates of progeny virus production of variants are such that D > A > B (panel a). Relative increase in virus output under TG inhibition (panel b) followed the same pattern as DMSO controls but was drastically reduced. Indicated significance of D is relative to B and A variants of each corresponding interval period based on 2-way ANOVA with Tukey’s multiple comparisons. Data shown are representative of three independent experiments and performed in quadruplicates

Article Snippet: Briefly, Vero E6 cells infected with a fixed volume of supernatant for 18 h were fixed with 4% paraformaldehyde in PBS for 15 min, permeabilized with 0.1% Triton X-100 in PBS for 10 min, washed three times with PBS, followed by peroxidase treatment for 10 min and incubation with a 1:1000 dilution of primary mouse monoclonal antibody, specific to the viral spike glycoprotein (1A9 clone, GeneTex GTX632604), at room temperature for 1 h. The cells were then washed with Tris-buffered saline (TBS), incubated with horse radish peroxidase-labeled polymer for 1 h. After further washing with TBS, the cells were incubated with DAB substrate-chromogen solution for a few min (Envision+ system-HRP kit, Dako).

Techniques: Control, Infection, Variant Assay, Incubation, Reverse Transcription, Virus, Inhibition

Replication rates of A, B and D variants in single variant- and co-infections . Data points, from earlier viral supernatant results of spike glycoprotein gene expression in single virus- and co-infections at 24, 48 and 72 hpi , were used to generate indicated growth curves and equations to determine the rate of viral RNA production (gradient) at a given time point. The D variant in single-variant infection, until saturation at 72 hpi, had the highest rate of viral RNA production relative to A and B variants in DMSO control (panel a) and TG-primed (panel b) Calu-3 cells. In co-infections, the D variant boosted the production rate of A and B variants (panel c and d) but at the expense of its initial performance (panel e). Negative values in production rate are likely due to virus saturation from limited cell number and even virus breakdown in media (panel a), or low initial virus growth (panel e). Data shown are representative of three independent experiments

Journal: Virulence

Article Title: Emergent SARS-CoV-2 variants: comparative replication dynamics and high sensitivity to thapsigargin

doi: 10.1080/21505594.2021.2006960

Figure Lengend Snippet: Replication rates of A, B and D variants in single variant- and co-infections . Data points, from earlier viral supernatant results of spike glycoprotein gene expression in single virus- and co-infections at 24, 48 and 72 hpi , were used to generate indicated growth curves and equations to determine the rate of viral RNA production (gradient) at a given time point. The D variant in single-variant infection, until saturation at 72 hpi, had the highest rate of viral RNA production relative to A and B variants in DMSO control (panel a) and TG-primed (panel b) Calu-3 cells. In co-infections, the D variant boosted the production rate of A and B variants (panel c and d) but at the expense of its initial performance (panel e). Negative values in production rate are likely due to virus saturation from limited cell number and even virus breakdown in media (panel a), or low initial virus growth (panel e). Data shown are representative of three independent experiments

Article Snippet: Briefly, Vero E6 cells infected with a fixed volume of supernatant for 18 h were fixed with 4% paraformaldehyde in PBS for 15 min, permeabilized with 0.1% Triton X-100 in PBS for 10 min, washed three times with PBS, followed by peroxidase treatment for 10 min and incubation with a 1:1000 dilution of primary mouse monoclonal antibody, specific to the viral spike glycoprotein (1A9 clone, GeneTex GTX632604), at room temperature for 1 h. The cells were then washed with Tris-buffered saline (TBS), incubated with horse radish peroxidase-labeled polymer for 1 h. After further washing with TBS, the cells were incubated with DAB substrate-chromogen solution for a few min (Envision+ system-HRP kit, Dako).

Techniques: Variant Assay, Gene Expression, Virus, Infection, Control

TG reduced vRNA synthesis and progeny production of Beta variant of SARS-CoV-2 in Calu-3 cells . Confluent cells were primed with 0.5 µM TG or DMSO control for 30 min, washed twice with PBS and infected with the B variant at 0.05 MOI in infection media for 3 h followed by three washes with PBS and incubated in fresh infection media. At indicated hpi, total cellular RNA was extracted (panel a); progeny virus in media was subjected to focus forming assay (FFA) (panel b) and viral RNA extraction (panel c). Total RNA was converted to cDNA for qPCR of SARS-CoV-2, normalized to 18s rRNA (panel a). FFA was based on the quantification of virus-positive Vero E6 cells at 18 hpi by immunochemical detection of viral spike glycoprotein (error bars = SEM; ns = not significant between time points) (panel b). Viral RNA from media was subjected to one-step reverse transcription qPCR to detect relative copy number of SARS-CoV-2, based on relative Ct method (panel c). Notably, despite increasing viral RNA accumulation in media of infected cells with time (panel c), viral gene expression (panel a) and infectious progeny virus (panel b) were in relative decline by 72 hpi. Indicated significance relative to corresponding DMSO control based on 2-way ANOVA with Sidak’s multiple comparisons. Indicated % refers to reduction in viral detection relative to corresponding DMSO control

Journal: Virulence

Article Title: Emergent SARS-CoV-2 variants: comparative replication dynamics and high sensitivity to thapsigargin

doi: 10.1080/21505594.2021.2006960

Figure Lengend Snippet: TG reduced vRNA synthesis and progeny production of Beta variant of SARS-CoV-2 in Calu-3 cells . Confluent cells were primed with 0.5 µM TG or DMSO control for 30 min, washed twice with PBS and infected with the B variant at 0.05 MOI in infection media for 3 h followed by three washes with PBS and incubated in fresh infection media. At indicated hpi, total cellular RNA was extracted (panel a); progeny virus in media was subjected to focus forming assay (FFA) (panel b) and viral RNA extraction (panel c). Total RNA was converted to cDNA for qPCR of SARS-CoV-2, normalized to 18s rRNA (panel a). FFA was based on the quantification of virus-positive Vero E6 cells at 18 hpi by immunochemical detection of viral spike glycoprotein (error bars = SEM; ns = not significant between time points) (panel b). Viral RNA from media was subjected to one-step reverse transcription qPCR to detect relative copy number of SARS-CoV-2, based on relative Ct method (panel c). Notably, despite increasing viral RNA accumulation in media of infected cells with time (panel c), viral gene expression (panel a) and infectious progeny virus (panel b) were in relative decline by 72 hpi. Indicated significance relative to corresponding DMSO control based on 2-way ANOVA with Sidak’s multiple comparisons. Indicated % refers to reduction in viral detection relative to corresponding DMSO control

Article Snippet: Briefly, Vero E6 cells infected with a fixed volume of supernatant for 18 h were fixed with 4% paraformaldehyde in PBS for 15 min, permeabilized with 0.1% Triton X-100 in PBS for 10 min, washed three times with PBS, followed by peroxidase treatment for 10 min and incubation with a 1:1000 dilution of primary mouse monoclonal antibody, specific to the viral spike glycoprotein (1A9 clone, GeneTex GTX632604), at room temperature for 1 h. The cells were then washed with Tris-buffered saline (TBS), incubated with horse radish peroxidase-labeled polymer for 1 h. After further washing with TBS, the cells were incubated with DAB substrate-chromogen solution for a few min (Envision+ system-HRP kit, Dako).

Techniques: Variant Assay, Control, Infection, Incubation, Virus, Focus Forming Assay, RNA Extraction, Reverse Transcription, Gene Expression

TG was effective in inhibiting emergent SARS-CoV-2 variants in pre-infected Calu-3 cells . Confluent cells were separately infected with SARS-CoV-2 variants at about 0.2 MOI for 2 h followed by three washes with PBS and incubated in fresh infection media. At 24 hpi, cultured media were removed and kept for re-seeding back to the same wells. Infected cells were then primed with 0.5 µM TG or DMSO control for 30 min, washed twice with PBS and the retained media were put back to the corresponding wells. At 48 and 72 hpi (i.e. at 24 h and 48 h post-priming with TG/DMSO respectively), viral RNA was extracted from spun supernatants for one-step reverse transcription qPCR to detect relative abundance of viral RNA that codes for spike glycoprotein (using primers 1 and 2). Notably, TG was able to inhibit preexisting active infection to great effect with a single 30 min exposure dose. Indicated significance relative to corresponding DMSO control based on 2-way ANOVA with Tukey’s multiple comparisons. Indicated % refers to reduction in viral detection relative to corresponding DMSO control

Journal: Virulence

Article Title: Emergent SARS-CoV-2 variants: comparative replication dynamics and high sensitivity to thapsigargin

doi: 10.1080/21505594.2021.2006960

Figure Lengend Snippet: TG was effective in inhibiting emergent SARS-CoV-2 variants in pre-infected Calu-3 cells . Confluent cells were separately infected with SARS-CoV-2 variants at about 0.2 MOI for 2 h followed by three washes with PBS and incubated in fresh infection media. At 24 hpi, cultured media were removed and kept for re-seeding back to the same wells. Infected cells were then primed with 0.5 µM TG or DMSO control for 30 min, washed twice with PBS and the retained media were put back to the corresponding wells. At 48 and 72 hpi (i.e. at 24 h and 48 h post-priming with TG/DMSO respectively), viral RNA was extracted from spun supernatants for one-step reverse transcription qPCR to detect relative abundance of viral RNA that codes for spike glycoprotein (using primers 1 and 2). Notably, TG was able to inhibit preexisting active infection to great effect with a single 30 min exposure dose. Indicated significance relative to corresponding DMSO control based on 2-way ANOVA with Tukey’s multiple comparisons. Indicated % refers to reduction in viral detection relative to corresponding DMSO control

Article Snippet: Briefly, Vero E6 cells infected with a fixed volume of supernatant for 18 h were fixed with 4% paraformaldehyde in PBS for 15 min, permeabilized with 0.1% Triton X-100 in PBS for 10 min, washed three times with PBS, followed by peroxidase treatment for 10 min and incubation with a 1:1000 dilution of primary mouse monoclonal antibody, specific to the viral spike glycoprotein (1A9 clone, GeneTex GTX632604), at room temperature for 1 h. The cells were then washed with Tris-buffered saline (TBS), incubated with horse radish peroxidase-labeled polymer for 1 h. After further washing with TBS, the cells were incubated with DAB substrate-chromogen solution for a few min (Envision+ system-HRP kit, Dako).

Techniques: Infection, Incubation, Cell Culture, Control, Reverse Transcription

Livers were collected from mice (n=6) sacrificed at respective time-points (2,4,8,12,24 & 48h for ANIT; 24 & 48h for CCl4; 6 & 24h for AlOH; and 10 d for BDL). RNA was isolated and cDNA was made using a commercial MMLV-RT kit. The cDNA samples were analyzed by quantitative RT-PCR using Fmo3 mouse-specific primers. Gene expression was normalized to the housekeeping gene β-actin. Fmo3 mRNA expression is presented as mean Fold Change ± SE. One-way ANOVA, t-test or two-way ANOVA was performed, appropriately, followed by the Dunnett's posttest for One-way ANOVA and the Bonferroni posttest for two-way ANOVA. Asterisks (*) represent a statistical difference (p < 0.05) between vehicle-treated and hepatotoxicant-treated or BDL group.

Journal: Toxicology

Article Title: Differential Fmo3 Gene Expression in Various Liver Injury Models Involving Hepatic Oxidative Stress in Mice

doi: 10.1016/j.tox.2014.08.013

Figure Lengend Snippet: Livers were collected from mice (n=6) sacrificed at respective time-points (2,4,8,12,24 & 48h for ANIT; 24 & 48h for CCl4; 6 & 24h for AlOH; and 10 d for BDL). RNA was isolated and cDNA was made using a commercial MMLV-RT kit. The cDNA samples were analyzed by quantitative RT-PCR using Fmo3 mouse-specific primers. Gene expression was normalized to the housekeeping gene β-actin. Fmo3 mRNA expression is presented as mean Fold Change ± SE. One-way ANOVA, t-test or two-way ANOVA was performed, appropriately, followed by the Dunnett's posttest for One-way ANOVA and the Bonferroni posttest for two-way ANOVA. Asterisks (*) represent a statistical difference (p < 0.05) between vehicle-treated and hepatotoxicant-treated or BDL group.

Article Snippet: Membranes were blocked with 5 % non-fat powdered milk in tris buffered saline containing 0.05% tween-20(TBS-T) for 8 h. A rabbit anti-mouse Fmo3 primary antibody (GenScript USA Inc., NJ) (1:5000) was used to detect Fmo3 with β-actin as a loading control.

Techniques: Isolation, Quantitative RT-PCR, Expressing

Western immunoblots for Fmo3 were performed using liver microsomes from control and hepatotoxicant-treated or BDL mice. A custom-made rabbit anti-mouse Fmo3 primary antibody, described in Materials and Methods was used to detect Fmo3. Fmo3 protein levels were normalized to β-actin loading control. Microsomal proteins isolated from naïve female mouse liver were used as a positive control (indicated by “+” sign). The data are presented as blots and as mean Fmo3 protein expression (Fold Change) ± SE. One-way ANOVA, t-test or two-way ANOVA was performed, appropriately, followed by the Dunnett's posttest for One-way ANOVA and the Bonferroni posttest for two-way ANOVA. Asterisks (*) represent a statistical difference (p < 0.05) between vehicle-treated and hepatotoxicant-treated or BDL group.

Journal: Toxicology

Article Title: Differential Fmo3 Gene Expression in Various Liver Injury Models Involving Hepatic Oxidative Stress in Mice

doi: 10.1016/j.tox.2014.08.013

Figure Lengend Snippet: Western immunoblots for Fmo3 were performed using liver microsomes from control and hepatotoxicant-treated or BDL mice. A custom-made rabbit anti-mouse Fmo3 primary antibody, described in Materials and Methods was used to detect Fmo3. Fmo3 protein levels were normalized to β-actin loading control. Microsomal proteins isolated from naïve female mouse liver were used as a positive control (indicated by “+” sign). The data are presented as blots and as mean Fmo3 protein expression (Fold Change) ± SE. One-way ANOVA, t-test or two-way ANOVA was performed, appropriately, followed by the Dunnett's posttest for One-way ANOVA and the Bonferroni posttest for two-way ANOVA. Asterisks (*) represent a statistical difference (p < 0.05) between vehicle-treated and hepatotoxicant-treated or BDL group.

Article Snippet: Membranes were blocked with 5 % non-fat powdered milk in tris buffered saline containing 0.05% tween-20(TBS-T) for 8 h. A rabbit anti-mouse Fmo3 primary antibody (GenScript USA Inc., NJ) (1:5000) was used to detect Fmo3 with β-actin as a loading control.

Techniques: Western Blot, Isolation, Positive Control, Expressing

Plasma and livers were collected from mice 72 h following APAP (400 mg/kg) or vehicle treatment. (A) The data are presented as mean plasma ALT (IU/L) ± SE. (B) RNA was isolated from livers andcDNA samples were analyzed by quantitative RT-PCR using Fmo3 mouse-specific primers. Gene expression was normalized to the housekeeping gene β-actin. Fmo3 mRNA expression are presented as mean Fold Change ± SE. Oneway ANOVA was performed followed by the Dunnett's post-test. Asterisks (*) represent a statistical difference (p < 0.05) between vehicle-treated group and APAP-treated group and hash (#) represent a statistical difference (p<0.05) compared with APAP-treated wild-type mice.

Journal: Toxicology

Article Title: Differential Fmo3 Gene Expression in Various Liver Injury Models Involving Hepatic Oxidative Stress in Mice

doi: 10.1016/j.tox.2014.08.013

Figure Lengend Snippet: Plasma and livers were collected from mice 72 h following APAP (400 mg/kg) or vehicle treatment. (A) The data are presented as mean plasma ALT (IU/L) ± SE. (B) RNA was isolated from livers andcDNA samples were analyzed by quantitative RT-PCR using Fmo3 mouse-specific primers. Gene expression was normalized to the housekeeping gene β-actin. Fmo3 mRNA expression are presented as mean Fold Change ± SE. Oneway ANOVA was performed followed by the Dunnett's post-test. Asterisks (*) represent a statistical difference (p < 0.05) between vehicle-treated group and APAP-treated group and hash (#) represent a statistical difference (p<0.05) compared with APAP-treated wild-type mice.

Article Snippet: Membranes were blocked with 5 % non-fat powdered milk in tris buffered saline containing 0.05% tween-20(TBS-T) for 8 h. A rabbit anti-mouse Fmo3 primary antibody (GenScript USA Inc., NJ) (1:5000) was used to detect Fmo3 with β-actin as a loading control.

Techniques: Isolation, Quantitative RT-PCR, Expressing

After overnight fasting, groups of wild-type and Nrf2 knockout mice received a single dose of 400 mg/kg APAP or vehicle. Livers were collected 72 h following APAP or vehicle treatments. Western blot for Fmo3 was performed using liver microsomes from control and APAP-treated mice. Equal protein loading (10 μg protein/lane) was confirmed by detection of β-actin. Microsomal proteins isolated from naïve female mouse liver were used as a positive control indicated by “+” sign. The data are presented as blots and as mean Fmo3 protein expression (Fold Change) ± SE (A). FMO activity was measured in liver microsomes from control and APAP-treated mice using methimazole as substrate. Data are presented as mean Specific Activity (μM/min/mg) ± SE (B). Asterisks (*) represent a statistical difference (p < 0.05) between vehicle-treated group and APAP-treated group and hash (#) represent a statistical difference (p<0.05) compared with APAP-treated wild-type mice.

Journal: Toxicology

Article Title: Differential Fmo3 Gene Expression in Various Liver Injury Models Involving Hepatic Oxidative Stress in Mice

doi: 10.1016/j.tox.2014.08.013

Figure Lengend Snippet: After overnight fasting, groups of wild-type and Nrf2 knockout mice received a single dose of 400 mg/kg APAP or vehicle. Livers were collected 72 h following APAP or vehicle treatments. Western blot for Fmo3 was performed using liver microsomes from control and APAP-treated mice. Equal protein loading (10 μg protein/lane) was confirmed by detection of β-actin. Microsomal proteins isolated from naïve female mouse liver were used as a positive control indicated by “+” sign. The data are presented as blots and as mean Fmo3 protein expression (Fold Change) ± SE (A). FMO activity was measured in liver microsomes from control and APAP-treated mice using methimazole as substrate. Data are presented as mean Specific Activity (μM/min/mg) ± SE (B). Asterisks (*) represent a statistical difference (p < 0.05) between vehicle-treated group and APAP-treated group and hash (#) represent a statistical difference (p<0.05) compared with APAP-treated wild-type mice.

Article Snippet: Membranes were blocked with 5 % non-fat powdered milk in tris buffered saline containing 0.05% tween-20(TBS-T) for 8 h. A rabbit anti-mouse Fmo3 primary antibody (GenScript USA Inc., NJ) (1:5000) was used to detect Fmo3 with β-actin as a loading control.

Techniques: Knock-Out, Western Blot, Isolation, Positive Control, Expressing, Activity Assay